Company Newron Pharmaceuticals SpA CBOE EUROPE EQUITIES
Equities
0QOI
IT0004147952
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
Business Summary
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100.0
%
| 6 | 100.0 % | 9 | 100.0 % | +43.85% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Italy & United States
100.0
%
| 6 | 100.0 % | 9 | 100.0 % | +43.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 60 | 12-05-14 |
Luca Benatti
FOU | Founder | 63 | 97-12-31 |
Roberto Galli
DFI | Director of Finance/CFO | - | 01-12-31 |
Filippo Moriggia
COO | Chief Operating Officer | - | 16-10-31 |
Ravi Anand
CTO | Chief Tech/Sci/R&D Officer | 67 | 04-12-31 |
Laura Faravelli
PRN | Corporate Officer/Principal | - | 18-12-31 |
Dennis Dionne
PRN | Corporate Officer/Principal | - | 14-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 07-12-31 | |
Luca Benatti
FOU | Founder | 63 | 97-12-31 |
Ulrich Köstlin
CHM | Chairman | 71 | 12-12-31 |
Stefan Weber
CEO | Chief Executive Officer | 60 | 12-05-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,631,834 | 17,069,414 ( 91.61 %) | 0 | 91.61 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- NWRN Stock
- 0QOI Stock
- Company Newron Pharmaceuticals SpA